Digital Therapeutics for Smoking Cessation in HIV Patients
HIV smoking cessation digital therapeutics show promise in engaging people living with HIV for tobacco cessation. Clinical trial data supports feasibility and acceptability of these tools. Technology-based interventions can reach this population…
Review of Cannabinoid Clinical Trials for Anxiety and Tourette
Cannabinoid clinical trials anxiety research reveals measurable reductions in anxiety symptoms across various disorders. Evidence supports modest but meaningful benefits, especially for generalized anxiety and Tourette syndrome. These findings highlight…
Understanding Cannabis Induced Psychosis and Schizophrenia Progression
Cannabis induced psychosis schizophrenia progression is a critical area of study for understanding long-term psychiatric risks. Patients with cannabis induced psychosis often face increased chances of developing schizophrenia spectrum disorders. Early…
Exploring Endocannabinoid System and Adolescent Psychiatric Risk
Endocannabinoid system adolescent psychiatric risk is a critical area of study linked to cannabis use in teens. Research shows increased risk of psychotic, bipolar, depressive, and anxiety disorders. Understanding this risk helps guide clinical practice…
Endocannabinoid System Research: Teen Cannabis Intervention
Sequential cannabis prevention messaging offers a promising approach to reduce cannabis use among adolescents. This strategy tailors messages to teens' beliefs and norms, improving engagement. Research shows it effectively lowers cannabis use intentions…
Endocannabinoid System Research: Cannabis & Child Development
Peripregnancy cannabis exposure is linked to behavioral and developmental differences in children, with varying effects based on autism spectrum disorder symptoms. This research highlights the importance of understanding maternal cannabis use during…
Review of Cannabinoid Clinical Trials in Mental Health and Substance Use Treatment
Cannabinoid clinical trials mental health substance use treatment research remains limited and inconclusive. Current randomized controlled trials have not firmly established cannabinoids as effective or safe primary treatments. Clinicians should…
Endocannabinoid System & Athlete Mental Health Research Insights
Mental health outcomes retired athletes face are shaped by complex factors including brain trauma and identity loss. Research on the endocannabinoid system offers insights into these challenges. This article reviews key findings on mental health outcomes…
Endocannabinoid System Research: Trauma, Sleep & Substance Use
Insomnia symptoms trauma substance use risk is a key factor in developing problematic alcohol or cannabis use after trauma. This relationship is partly explained by posttraumatic stress symptoms. Clinicians should assess sleep disturbance as an early…
Cannabinoids for Autism: Clinical Evidence-Based Review
Cannabinoid clinical trials autism research shows promising signals for reducing irritability and hyperactivity in autism spectrum disorder. Evidence is limited by small sample sizes and trial variability. Larger, well-controlled studies are needed for…
